MCK vs HSIC vs MDLN Stock Comparison

Mckesson, Henry Schein and Medline Prices as of Nov 13, 2026 Peers: Industry group
MCK Mckesson Corp
$1,102.82 +12.7% 1M +30.3% 1Y
Market cap
$129.18B
P/E
27.5x
Revenue (TTM)
$418.79B
Div. yield
0.00%
Drug Distribution Healthcare
7 wins
HSIC Henry Schein Inc
$86.22 +0.8% 1M +17.6% 1Y
Market cap
$9.44B
P/E
22.4x
Revenue (TTM)
$13.73B
Div. yield
0.00%
Drug Distribution Healthcare
4 wins
MDLN Medline Inc.
$39.47 +9.9% 1M
Market cap
$34.15B
P/E
40.6x
Revenue (TTM)
$30.68B
Div. yield
–
Medical Supplies Healthcare

Head to Head

11 decided of 12

Mckesson leads on 7 of the 12 questions below (Mckesson 7, Henry Schein 4). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionMCKHSICMDLNLeader
Larger companyMarket capitalisation $129.18B $9.44B $34.15B MCK
Cheaper on earningsLower P/E, profitable companies only 27.5x 22.4x 40.6x HSIC
Cheaper on forward earningsLower price / next fiscal year consensus EPS 22.8x 14.6x 26.5x HSIC
Faster revenue growthRevenue growth, trailing twelve months +8.2% +6.2% — MCK
More profitableNet margin, trailing twelve months 1.1% 3.1% 2.7% HSIC
Better return on capitalReturn on invested capital 98.7% 7.3% 4.3% MCK
Less leveragedLower net debt / EBITDA 0.4x 3.2x 3.2x MCK
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +30.3% +17.6% — MCK
Better 5-year returnAnnualised price return, 5 years +37.5%/yr +1.7%/yr — MCK
Less volatileAnnualised volatility, 1 year 31.4% 25.2% 47.8% HSIC
Higher overall scoreMean of the five percentile scores vs peers 58/100 57/100 53/100 MCK

Percentile Scorecard

MCKHSICMDLN

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisMCKHSICMDLN
Valuation 65 #10 of 27 46 #15 of 27 78 #54 of 243
Growth 56 #12 of 26 48 #14 of 26 –
Profitability 56 #12 of 26 76 #7 of 26 73 #60 of 222
Financial Health 56 #12 of 26 20 #21 of 26 43 #143 of 248
Shareholder Returns 59 #8 of 18 94 #2 of 18 17 #132 of 158
Overall 58 57 53
  • MCK ranked among 27 companies in Healthcare Payers and Distributors
  • HSIC ranked among 27 companies in Healthcare Payers and Distributors
  • MDLN ranked among 252 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodMCKHSICMDLNSPY
1 month +12.7%+0.8%+9.9% -2.0%
3 months +26.9%-4.0%+10.4% -2.8%
6 months +45.0%+18.6%+9.1% +2.0%
Year to date +34.4%+14.1%-6.0% +10.6%
1 year +30.3%+17.6%— +12.2%
3 years +143.0%+25.1%— +68.1%
3 years, per year +34.5%+7.8%— +18.9%
5 years +390.5%+8.8%— +61.4%
5 years, per year +37.5%+1.7%— +10.1%
10 years +671.0%+40.3%— +248.5%
10 years, per year +22.7%+3.4%— +13.3%

Risk

MeasureMCKHSICMDLNSPY
Volatility, 1Y 31.4%25.2%47.8% 13.6%
Downside volatility, 1Y 27.2%25.4%48.2% 13.9%
Beta vs S&P 500, 1Y -0.180.630.74 1.00
Return / volatility, 1Y 0.970.70— 0.90
Max drawdown, 5Y -27.2%-32.7%-36.7% -25.4%
From 52-week high 0.0%-5.1%-21.0% -3.2%
52-week high $1,102.82$90.86$49.99 $779.14
52-week low $725.17$68.99$31.64 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleMCKHSICMDLN
P/E now vs peer median 27.3xmedian 25.2x 22.8xmedian 25.2x 41.1xmedian 26.5x
P/S now vs peer median 0.3xmedian 0.4x 0.7xmedian 0.4x 1.7xmedian 2.7x
EV/EBITDA now vs peer median 17.4xmedian 14.5x 12.4xmedian 14.5x 21.6xmedian 18.4x
P/FCF now vs peer median 17.9xmedian 16.5x 17.0xmedian 16.5x 27.4xmedian 25.4x
P/B now vs peer median -32.2xmedian 2.7x 2.5xmedian 2.7x 2.7xmedian 2.5x
PEG now vs peer median 1.72median 1.72 6.74median 1.72 —median 0.98

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsMCKHSICMDLN
Revenue $418.79B $13.73B $30.68B
Gross profit $15.37B $4.34B $7.90B
Operating income $6.69B $709.00M $1.74B
Net income $5.43B $443.00M $889.00M
Free cash flow $7.11B $559.00M $1.90B
EPS (diluted) $40.27 $3.74 $0.64
Cash & equivalents $6.53B $184.00M $2.32B
Total debt $9.21B $3.52B $12.58B
Shares (diluted) 116.70M 112.54M 1.32B
Enterprise value $110.56B $9.26B $23.69B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricMCKHSICMDLN
P/E 27.3x 22.8x 41.1x
P/FCF 17.9x 17.0x 27.4x
P/Operating cash flow 17.0x 13.9x 21.8x
P/S 0.3x 0.7x 1.7x
P/B -32.2x 2.5x 2.7x
P/Tangible book -16.1x 3.3x 8.6x
EV/EBITDA 17.4x 12.4x 21.6x
EV/EBIT 19.4x 18.2x 35.0x
EV/Revenue 0.3x 0.9x 2.0x
EV/FCF 18.3x 23.0x 32.1x
EV/Operating cash flow 17.3x 18.7x 25.6x
PEG (3Y EPS CAGR) 1.72 6.74 –

Growth

14 metrics
MetricMCKHSICMDLN
Revenue growth (1Y) 8.2% 6.2% –
Revenue CAGR (3Y) 12.9% 2.7% –
Gross profit growth (1Y) 11.8% 7.5% –
Gross profit CAGR (3Y) 7.6% 3.3% –
Operating income growth (1Y) 27.3% 9.9% –
Operating income CAGR (3Y) 16.1% 3.0% –
Net income growth (1Y) 28.5% 7.5% –
Net income CAGR (3Y) 14.2% -2.0% –
EPS growth (1Y) 24.2% 15.8% –
EPS CAGR (3Y) 15.9% 3.4% –
Operating cash flow growth (1Y) 9.3% 28.4% –
Operating cash flow CAGR (3Y) 15.2% -4.4% –
Free cash flow growth (1Y) 11.8% 38.7% –
Free cash flow CAGR (3Y) 16.3% -4.9% –

Profitability

14 metrics
MetricMCKHSICMDLN
Gross margin 3.7% 31.6% 25.7%
EBITDA margin 1.8% 7.6% 9.2%
Operating margin 1.6% 5.2% 5.7%
Pretax margin 1.6% 4.2% 3.6%
Net margin 1.1% 3.1% 2.7%
FCF margin 1.7% 4.1% 6.2%
Operating cash flow margin 1.8% 5.0% 7.8%
Return on equity – 11.6% 4.6%
Return on assets 6.0% 3.9% 2.2%
Return on invested capital 98.7% 7.3% 4.3%
Return on capital employed 42.0% 9.0% 4.8%
Asset turnover 4.6x 1.2x 0.8x
Cash conversion (OCF / net income) 1.4x 1.6x 2.7x
Stock comp / revenue – 0.3% 0.4%

Financial Health

11 metrics
MetricMCKHSICMDLN
Debt / assets 10.0% 30.6% 31.3%
Debt / equity -2.3x 0.9x 0.6x
Net debt / EBITDA 0.4x 3.2x 3.2x
Debt / FCF 1.3x 6.3x 6.6x
Liabilities / assets 104.3% 66.8% 51.7%
Equity / assets -4.3% 33.2% 48.3%
Interest coverage 21.9x 4.3x –
Current ratio 0.9x 1.3x 4.0x
Quick ratio 0.5x 0.6x 2.4x
Cash ratio 0.1x 0.1x 1.2x
Altman Z-score 5.83 2.65 2.70

Shareholder Returns

7 metrics
MetricMCKHSICMDLN
Dividend yield 0.3% – –
Net buyback yield 5.2% 6.8% -13.6%
Shareholder yield 5.6% 6.8% -13.6%
Payout ratio (earnings) 7.4% 6.8% –
Payout ratio (FCF) 5.6% 5.4% –
Dividend growth (1Y) 10.5% – –
Dividend CAGR (3Y) 9.8% – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusMCKHSICMDLN
Forward P/E 22.8xFY2026 14.6xFY2026 26.5xFY2026
EPS, next fiscal year $48.34FY2026 $5.89FY2026 $1.49FY2026
EPS growth, next FY +23.6%FY2026 +18.5%FY2026 +4.2%FY2026
EPS growth, the year after +11.9% +5.9% +9.4%
Revenue, next fiscal year $447.65BFY2026 $13.36BFY2026 $32.69BFY2026
Revenue growth, next FY +11.0%FY2026 +1.3%FY2026 +15.0%FY2026
Revenue growth, the year after +1.5% +4.6% +8.2%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersMCKHSICMDLN
Held by institutions 89.1% 100.0% 57.1%
Institutions holding 2,014 566 409
Change in shares held, QoQ -0.7% +2.1% +17.9%
Institutions buying 883 244 322
Institutions selling 793 217 69
Buyers to sellers 1.11 1.12 4.67

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

MCKHSICMDLN
MCK 1.00 0.32 0.24
HSIC 0.32 1.00 0.40
MDLN 0.24 0.40 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, MCK, HSIC and MDLN?

Mckesson (MCK) is the largest by market capitalisation: Mckesson (MCK) $129.18B, Henry Schein (HSIC) $9.44B, Medline (MDLN) $34.15B.

Which stock is cheaper, MCK, HSIC and MDLN?

Henry Schein (HSIC) trades on the lowest price-to-earnings ratio (Mckesson (MCK) 27.5x, Henry Schein (HSIC) 22.4x, Medline (MDLN) 40.6x). On next year's consensus earnings, Henry Schein (HSIC) is cheapest (Mckesson (MCK) 22.8x, Henry Schein (HSIC) 14.6x, Medline (MDLN) 26.5x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Mckesson (MCK) grew revenue fastest over the trailing twelve months: Mckesson (MCK) +8.2%, Henry Schein (HSIC) +6.2%.

Which company is more profitable?

Henry Schein (HSIC) has the highest net margin (Mckesson (MCK) 1.1%, Henry Schein (HSIC) 3.1%, Medline (MDLN) 2.7%). On return on invested capital, Mckesson (MCK) leads (Mckesson (MCK) 98.7%, Henry Schein (HSIC) 7.3%, Medline (MDLN) 4.3%).

Which stock has performed better?

Over the past year Mckesson (MCK) returned the most: Mckesson (MCK) +30.3%, Henry Schein (HSIC) +17.6%. Over five years, Mckesson (MCK) compounded fastest (Mckesson (MCK) +37.5%/yr, Henry Schein (HSIC) +1.7%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Mckesson (MCK) 0.00%, Henry Schein (HSIC) 0.00%, Medline (MDLN) 0.00%. Henry Schein (HSIC) and Medline (MDLN) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Henry Schein (HSIC) has been the steadiest (Mckesson (MCK) 31.4%, Henry Schein (HSIC) 25.2%, Medline (MDLN) 47.8%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, MCK, HSIC and MDLN?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Mckesson (MCK) leads on 7. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.